(Q38453913)

3 September 2017

1 reference

title

Novel treatment strategies for feline chronic kidney disease: A critical look at the potential of mesenchymal stem cell therapy (English)

1 reference

chronic renal insufficiency

3 September 2017

main subject

mesenchymal stem cell

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Chronic kidney disease in cats

1 reference

J M Quimby

1

1 reference

3 September 2017

S W Dow

series ordinal

2

1 reference

3 September 2017

publication date

9 April 2015

1 reference

3 September 2017

published in

The Veterinary Journal

1 reference

3 September 2017

volume

204

1 reference

3 September 2017

issue

3

1 reference

3 September 2017

page(s)

241-246

1 reference

Concise review: stem/progenitor cells for renal tissue repair: current knowledge and perspectives

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Mesenchymal stem cells: immune evasive, not immune privileged

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Immunogenicity of adult mesenchymal stem cells: lessons from the fetal allograft.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Histomorphometry of feline chronic kidney disease and correlation with markers of renal dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

The role of mesenchymal stem cells in the functional improvement of chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Effects of adipose-derived mesenchymal cells on ischemia-reperfusion injury in kidney.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Human adipose-derived cells: an update on the transition to clinical translation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Could fetal fluid and membranes be an alternative source for mesenchymal stem cells (MSCs) in the feline species? A preliminary study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Uremic toxins impair human bone marrow-derived mesenchymal stem cells functionality in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Oxidative stress and neutrophil function in cats with chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Improvement of kidney failure with fetal kidney precursor cell transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Functional aftereffects of intraparenchymatous injection of human fetal stem and progenitor cells to rats with chronic and acute renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Isolation, characterization, and in vitro proliferation of canine mesenchymal stem cells derived from bone marrow, adipose tissue, muscle, and periosteum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Establishment and characterization of renal progenitor like cells from S3 segment of nephron in rat adult kidney.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Mesenchymal stem cells from rats with chronic kidney disease exhibit premature senescence and loss of regenerative potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Repeated administration of bone marrow-derived mesenchymal stem cells improved the protective effects on a remnant kidney model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Biological character of human adipose-derived adult stem cells and influence of donor age on cell replication in culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Mesenchymal stromal cell therapy for Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Review article: Potential cellular therapies for renal disease: can we translate results from animal studies to the human condition?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Isolation and characterization of multipotential mesenchymal stem cells from feline bone marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Canine adipose-derived-mesenchymal stem cells do not lose stem features after a long-term cryopreservation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Evolution and future prospects of adipose-derived immunomodulatory cell therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Uremia induces functional incompetence of bone marrow-derived stromal cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Evaluation of intrarenal mesenchymal stem cell injection for treatment of chronic kidney disease in cats: a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Mesenchymal stem cells derived from adipose tissue are not affected by renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Concise review: adipose tissue-derived stromal cells--basic and clinical implications for novel cell-based therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Age of the donor reduces the ability of human adipose-derived stem cells to alleviate symptoms in the experimental autoimmune encephalomyelitis mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Mesenchymal stem cells ameliorate tissue damages triggered by renal ischemia and reperfusion injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Long-term evaluation of mesenchymal stem cell therapy in a feline model of chronic allergic asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Healthy bone marrow cells reduce progression of kidney failure better than CKD bone marrow cells in rats with established chronic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Mesenchymal stem cell injection ameliorates chronic renal failure in a rat model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Human mesenchymal stem cells derived from adipose tissue reduce functional and tissue damage in a rat model of chronic renal failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Cell therapy with autologous mesenchymal stem cells-how the disease process impacts clinical considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

In vitro comparison of feline bone marrow-derived and adipose tissue-derived mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Comparison of multipotency and molecular profile of MSCs between CKD and healthy rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Autologous cell therapy for cisplatin-induced acute kidney injury by using non-expanded adipose tissue-derived cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

Therapeutic doses of multipotent stromal cells from minimal adipose tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.04.007

10.1016/J.TVJL.2015.04.007

7 January 2021

Identifiers

DOI

1 reference

3 September 2017

1 reference